Skip to main content
SpringerLink
Log in

Hepato-splanchnic circulation in human hypertension

  • Chapter
Arterial and Venous Systems in Essential Hypertension

Part of the book series: Developments in Cardiovascular Medicine ((DICM,volume 63))

  • 52 Accesses

Abstract

Under normal conditions, the hepato-splanchnic circulation receives a large portion of the cardiac output (about 25%), contains a substantial fraction of the blood volume (about 20%) and provides a major share of the total body lymph flow and transvascular protein flux [1]. Therefore, hypertension-induced changes in the vasculature of this region can play a significant role in systemic hemodynamics.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Nyhof RA, Laine GA, Meininger GA, Granger HJ (1983): Splanchnic circulation in hypertension. Federation Proc 42: 1690–1693.

    CAS  Google Scholar 

  2. Simon G, Pamnani MB, Dunkel JF, Overbeck HW (1975): Mesenteric hemodynamics in early experimental renal hypertension in dogs. Circul Res 36: 791–798.

    CAS  Google Scholar 

  3. Benhamou JP, Sicot C, Erlinger S (1971): Exposes de physiologie et de physiopathologie hépatique. La Presse Médicale, 79: 185–191.

    PubMed  CAS  Google Scholar 

  4. Caesar J, Shaldon S, Chiandussi L, Guevara L, Sherlock S (1961): The use of indocyanin green in the measurement of hepatic blood flow. Clin Sci 21: 43–57.

    PubMed  CAS  Google Scholar 

  5. Weiss YA, Safar ME, Lehner JP, Levenson JA, Simon A, Alexandre JM (1978): (+)-propranolol clearance, an estimation of hepatic blood flow in man. Br J Clin Pharmacol 5: 457–460.

    PubMed  CAS  Google Scholar 

  6. Messerli FH, De Carvalho JGR, Christie B, Frohlich ED (1978): Systemic and regional hemodynamics in low, normal and high cardiac output borderline hypertension. Circulation 58: 441–448.

    PubMed  CAS  Google Scholar 

  7. Tait JF, Bougas J, Little B, Tait SAS, Flood C (1965): Splanchnic extraction and clearance of aldosterone in subjects with minimal and marked cardiac dysfunction. J Clin Endocrin Metab 25: 219–225.

    Article  CAS  Google Scholar 

  8. Stenson RE, Constantino RT, Harrison DC (1971): Interrelationship of hepatic blood flow, cardiac output and blood levels of lidocaine in man. Circulation 43: 205–211.

    PubMed  CAS  Google Scholar 

  9. Nies AS, Evans GH, Shand DG (1972): The hemodynamic effects of beta-adrenergic blockade on the flow-dependent hepatic clearance of propranolol J Pharmacol Exp Ther 184: 716–722.

    Google Scholar 

  10. Weiss YA, Safar ME, Chevillard C, Frydman A, Simon A, Lemaire P, Alexandre JM (1976): Comparison of the pharmacokinetics of intravenous dl-Propranolol in borderline and permanent hypertension. Europ J Clin Pharmacol 10: 387–393.

    Article  CAS  Google Scholar 

  11. Safar ME, Simon ACh, Dard SA, Parlier HR, Pauleau NE, Vincent ML, Sassard JE (1982): Aldosterone in sustained essential hypertension. Clinical Endocrinology 16: 77–88.

    Article  PubMed  CAS  Google Scholar 

  12. Brod J (1960): Essential hypertension. Hemodynamic observations with a bearing on its pathogenesis. Lancet 1: 773–778.

    Article  Google Scholar 

  13. Culbertson JW, Wilkins RW, Ingelfinger FJ, Bradley SE (1951): The effect of the upright posture on hepatic blood flow in normotensive and hypertensive subjects. J Clin Invest 30: 305–311.

    Article  PubMed  CAS  Google Scholar 

  14. Wilkins RW, Culbertson JW, Rymut AA (1957): The hepatic blood flow in resting hypertensive patients before and after splanchnicectomy. J Clin Invest 31: 529–531.

    Article  Google Scholar 

  15. Temmar MM, Safar ME, Levenson JA, Totomoukouo JM, Simon ACh (1981): Regional blood flow in borderline and sustained essential hypertension. Clincial Science 60: 653–658.

    CAS  Google Scholar 

  16. Messerli FH, Genest J, Nowaczynski W, Kuchel O, Honda M, Latour Y, Dumont G (1975): Splanchnic blood flow in essential hypertension and in hypertensive patients with renal artery stenosis. Circulation 51: 1114–1119.

    PubMed  CAS  Google Scholar 

  17. Caldini P, Permutt S, Waddel JA, Riley RL (1974): Effect of epinephrine on pressure, flow and volume relationship in the systemic circulation of dogs. Circulation Research 34: 602–623.

    Google Scholar 

  18. Bashour FA, McClelland R, Nafrawi A (1963): Effects of angiotensin and splanchnic circulation and liver in dogs. L Lab Clin Med 62: 857–865.

    Google Scholar 

  19. Chiandussi L, Vaccarino A, Greco F, Muratori F, Cesano L, Indovina D (1963): Effect of drug infusion on the splanchnic circulation. I. Angiotensin infusion in normal and cirrhotic subjects. Proc Soc Exp Biol Med 112: 324–337.

    PubMed  CAS  Google Scholar 

  20. Bralet AM, Wepierre J, Bralet J (1973): Distribution of cardiac output and nutritional blood flow in the unanesthetized rat: alterations during experimental renal hypertension. Pfluegers Arch 343: 257–264.

    Article  CAS  Google Scholar 

  21. Safar ME, Weiss YA, Fontaliran FM, Simon AC, Pauleau NF (1978): Renovascular hypertension: relationship between hepatic blood flow and plasma renin activity. Nephron 20: 119–123.

    Article  PubMed  CAS  Google Scholar 

  22. Nowaczynski W, Kuchel O, Genest J (1971): A decreased metabolic clearance rate of aldosterone in benign essential hypertension. J Clin Invest 50: 2184–2191.

    Article  PubMed  CAS  Google Scholar 

  23. Kaufmann W, Steiner B, Durr F, Nieth H, Behn C (1967): Aldosteronstoffwechsel bei Nierenarterienstenose. Klin Wochenschr 45: 966–974.

    Article  PubMed  CAS  Google Scholar 

  24. Safar ME, London GM (1985): Venous system in essential hypertension. Cli Science 69: 497–504.

    CAS  Google Scholar 

  25. Svensson CK, Cumella JC, Tronolone M, Middleton E, Lalka D (1985): Effects of hydralazine, nitroglycerin, and food on estimated hepatic blood flow. Clin Pharmacol Ther 37: 464–468.

    Article  PubMed  CAS  Google Scholar 

  26. Crossley IR, Bihari D, Gimson AES, Westaby D, Richardson IJ, Williams R (1984): Effect of converting enzyme inhibitor on hepatic blood flow in man. Amer J Med 76 (5B): 62–66.

    Article  PubMed  CAS  Google Scholar 

  27. Safar ME, Chau NPh, Levenson JA, Simon ACh, Weiss YA (1978): Pharmacokinetics of intravenous and oral pindolol in hypertensive patients with chronic renal failure. Clin Science and Mol Med 55: 275s-277s.

    CAS  Google Scholar 

  28. Braillon A, Jiron MI, Valla D, Cales P, Lebreck D (1985): Effect of propranolol on hepatic blood flow in patients with cirrhosis. Clin Pharmac Therapeut 37: 376–380.

    Article  CAS  Google Scholar 

  29. George CF (1979): Drug kinetics and hepatic blood flow. Clin Pharmacol Cokinet 4: 433–438.

    Article  CAS  Google Scholar 

  30. Chau NPh, Weiss YA, Safar ME, Lavene DE, Georges DR, Milliez PL (1977): Pindolol availability in hypertensive patients with normal and impaired renal function. Clinical Pharmacol and Therapeut 22: 505–510.

    CAS  Google Scholar 

  31. Lavene DE, Weiss YA, Safar ME, Loria Y, Agoras N, Georges D, Milliez PL (1977): Pharmacokinetics and hepatic extraction ratio of pindolol in hypertensive patients with normal and impaired renal function. J Clin Pharmacol 17: 501–508.

    PubMed  CAS  Google Scholar 

  32. London GM, Safar ME, Weiss YA, Milliez PL (1976): Isoproterenol sensitivity and total body clearance of propranolol in hypertension patients. J Clin Pharmacol 16: 174–182.

    PubMed  CAS  Google Scholar 

  33. Shand DG, Evans GH, Nies AS (1971): The almost complete hepatic extraction of propranolol during intravenous administration in the dog. Life Sci 10: 1417–1421.

    Article  CAS  Google Scholar 

Download references

Authors
  1. Y. A. Weiss
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. H. London
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. E. Safar
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Diagnostic Center, Department of Internal Medicine, Hôpital Broussais, Paris, France

    M. E. Safar

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Martinus Nijhoff Publishers, Dordrecht.

About this chapter

Cite this chapter

Weiss, Y.A., London, G.H., Safar, M.E. (1987). Hepato-splanchnic circulation in human hypertension. In: Safar, M.E., London, G.M., Simon, A.C., Weiss, Y.A. (eds) Arterial and Venous Systems in Essential Hypertension. Developments in Cardiovascular Medicine, vol 63. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-3303-3_15

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-3303-3_15

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-7983-9

  • Online ISBN: 978-94-009-3303-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation